Polarean Inc
Polarean Inc, based in Durham, NC, is a revenue-generating medical imaging technology company specializing in high-resolution imaging for pulmonary medicine. The company aims to revolutionize respiratory healthcare by leveraging MRI technology to evaluate lung function, diagnose diseases, monitor disease progression, and assess treatment responses.
With a focus on hyperpolarization science, Polarean has developed the first FDA-approved hyperpolarized MRI contrast agent, XENOVIEW xenon Xe 129, for visualizing and quantifying gas exchange in the lungs. Led by a team of experienced executives, including CEO Christopher von Jako and Founder/CTO Bastiaan Driehuys, Polarean is dedicated to addressing the global unmet medical needs of millions of patients with chronic respiratory diseases.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.